FIELD: medicine, oncology, biology.
SUBSTANCE: method involves per os administration of the preparation "oligokhit activ" to a cancer carrier in the dose 20-24 mg/kg of weight for 7 days, not less. Method provides elimination of dystrophic changes in hepatocytes caused by metabolic disturbances in body of a cancer carrier, to improve proliferative activity of hepatocytes and to recover microcirculation.
EFFECT: improved correction method.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION AND METHOD FOR TUMOR TISSUE DESTRUCTION AND CORRECTION OF ORGANISM WITH TUMOR ENDOGENOUS INTOXICATION | 2006 |
|
RU2319486C1 |
| PREPARATION FOR INHIBITING TUMOR GROWTH AND METHOD FOR INHIBITING TUMOR GROWTH IN EXPERIMENT | 2006 |
|
RU2320334C1 |
| METHOD OF STIMULATING DYSTROPHIC CHANGES IN TUMOUR TISSUE | 2008 |
|
RU2379070C1 |
| POLYMER COMPLEX OF CHITOSAN WITH PLATINUM TETRACHLORIDE | 2009 |
|
RU2426547C1 |
| METHOD FOR INHIBITING PLISS LYMPHOSARCOMA GROWTH EXPERIMENTALLY | 2014 |
|
RU2561294C1 |
| N-[3-OXO-LUPANO-28-YL]-PIPERIDINE - AGENT HAVING ANTI-TUMOUR, ANTI-METASTATIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE ACTIVITY | 2011 |
|
RU2466136C1 |
| METHOD FOR TUMOUR GROWTH INHIBITION IN EXPERIMENT | 2012 |
|
RU2506971C1 |
| N-[3-OXO-LUPANO-28-YL]-MORPHOLINE - AGENT FOR CORRECTION OF CYTOTOXIC LIVER DAMAGES WITH ANTITUMOUR AND ANTIMETASTATIC ACTIVITY | 2011 |
|
RU2461563C1 |
| METHOD FOR SIMULATING LIVER METASTASES EXPERIMENTALLY | 2013 |
|
RU2538243C1 |
| METHOD OF TREATING NON-SPECIFIC REACTIVE HEPATITIS | 2011 |
|
RU2494776C2 |
